Invention Grant
- Patent Title: RSV F protein mutants
-
Application No.: US15385611Application Date: 2016-12-20
-
Publication No.: US09950058B2Publication Date: 2018-04-24
- Inventor: Ye Che , Philip Ralph Dormitzer , Alexey Vyacheslavovich Gribenko , Luke David Handke , Avvari Krishna Prasad , Xiayang Qiu , Mark Edward Ruppen , Xi Song , Kena Anne Swanson , Srinivas Kodali , Xin Xu , KariAnn Sweeney Efferen , Ping Cai , Kristin Rachael Tompkins , Lorna del Pilar Nunez
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Austin W. Zhang
- Main IPC: A61K39/155
- IPC: A61K39/155 ; C07K14/135 ; C12N15/01 ; C07K14/005 ; C12N7/00 ; A61K39/12 ; A61K39/00
Abstract:
The present disclosure relates to RSV F protein mutants, nucleic acids or vectors encoding a RSV F protein mutant, compositions comprising a RSV F protein mutant or nucleic acid, and uses of the RSV F protein mutants, nucleic acids or vectors, and compositions.
Public/Granted literature
- US20170182151A1 RSV F Protein Mutants Public/Granted day:2017-06-29
Information query
